Company: CI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001739940-25-000009
Chunk: 1004

Company: Cigna Group
Filing Date: 2025-02-27
Form: 10-K
Item: Item 3
Chunk 1004
---
 viewed as a substitute for the most directly comparable GAAP measure, total revenues. See the below Financial Highlights section for a reconciliation of consolidated adjusted revenues to total revenues.

EXECUTIVE OVERVIEW

The Cigna Group, together with its subsidiaries (either individually or collectively referred to as the "Company," "we," "us" or "our"), is a global health company committed to creating a better future for every individual and every community. Our subsidiaries offer a differentiated set of pharmacy, medical, behavioral, dental, and related products and services. For further information on our business and strategy, see Part I, Item 1 "Business" of this Form 10-K. 

38

Financial Highlights

Consolidated Results of Operations (GAAP basis)For the Years Ended December 31,ChangeChange(Dollars in millions)2024202320222024 vs. 20232023 vs. 2022Pharmacy revenues$185,362 $137,243 $128,566 $48,119 35 %$8,677 7 %Premiums45,996 44,237 39,916 1,759 4 4,321 11 Fees and other revenues14,790 12,619 10,881 2,171 17 1,738 16 Net investment income973 1,166 1,155 (193)(17)11 1 Total revenues247,121 195,265 180,518 51,856 27 14,747 8 Pharmacy and other service costs182,509 133,801 124,834 48,708 36 8,967 7 Medical costs and other benefit expenses38,648 36,287 32,184 2,361 7 4,103 13 Selling, general and administrative expenses14,844 14,822 13,174 22 — 1,648 13 Amortization of acquired intangible assets1,703 1,819 1,876 (116)(6)(57)(3)Total benefits and expenses237,704 186,729 172,068 50,975 27 14,661 9 Income from operations9,417 8,536 8,450 881 10 86 1 Interest expense and other(1,435)(1,446)(1,228)11 (